'Coronary event' diaporamas de présentation

Aggressive Lipid Lowering Treatment

Aggressive Lipid Lowering Treatment. Richard CESKA Centre of Preventive Cardiology University Hospital, Prague, Czech Republic International Atherosclerosis Society Chair: Federation for EUROPE. Dyslipidemia Management. Part of the complex approach to decrease CV RISK.

1.05k views • 92 slides

Chapter 5 Psychology and Physical Health

1.14k views • 66 slides

Rheumatoid Arthritis Update

Rheumatoid Arthritis Update. Ivonne Herrera, MD Rheumatologist July 20, 2013. Disclosure. Nothing to be disclosed. Outline. Clinical presentation Diagnosis: New diagnostic criteria for RA (2010) Morbidity and Mortality Treatment options. Pierre Auguste Renoir 1841-1919.

884 views • 46 slides

Subacute Care and Continuous Cardiac Monitoring

Subacute Care and Continuous Cardiac Monitoring. Peggy Beeley, MD June 7th , 2010. Objectives. Understand Current Availability & Utilization of Cardiac Telemetry at UH Understand Current Availability & Utilization of Subacute care at UH

501 views • 33 slides

412 views • 31 slides

Capri Cardiovascular Conference 2.0 28/29 Marzo 2014

T2238C ANP gene variant and risk of recurrent myocardial infarction in a cohort of Italian patients with ischemic heart disease. A retrospective study.

273 views • 10 slides

Landmark Statin Trials Across the Spectrum of Risk: Secondary Stroke Prevention

Landmark Statin Trials Across the Spectrum of Risk: Secondary Stroke Prevention. Simvastatin in Patients With Prior Cerebrovascular Disease: HPS. 29.8. 24.7*. Simvastatin. Placebo. 10.3. 10.4. (N=488). N=406. N=169. N=170. Major Vasular Events. Stroke. *29% RRR, p =0.001

319 views • 7 slides

*p=.004; p=.005 for interaction

Prospective Pravastatin Pooling Project: Coronary Event Rates in CARE and LIPID Patients with Baseline LDL-C <125 mg/dL. *p=.004; p=.005 for interaction. Sacks FM et al. Circulation 2002;105:1424-1428.

150 views • 4 slides